Historical AI Consensus
This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.
- Symbol
- BBAI.NYSE
- Batch
- 7
- Published
- September 20, 2026
- AI Advisors
- 14
Historical AI Consensus Investment Thesis
BigBear.ai (BBAI) Stock Forecast and AI Rating
Forecast targets and rating
Published batch rating
PARTIAL SELL
Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.
1-Year
SELL ALL$2.40
-14.1%5-Year
PARTIAL SELL$1.95
-30.2%Published batch insight
Defense Software Multiple Deflates as Relentless Dilution Erases Topline Gains
There is sharp divergence between headline AI turnaround narratives and underlying equity mechanics. While consensus acknowledges balance sheet solvency via $409.8 million in cash, persistent negative free cash flow and continuous share dilution structurally compress elevated sales multiples toward defense services reality.
This analysis preserves the original published batch. Audit published forecasts in full transparency
Universal Investor (Polymath), Michael Burry (Vulture), Superintelligence (Anthropologist), Warren Buffett (Value Purist), Sherlock Holmes (Whistleblower), Machiavelli (Insider), Elon Musk (Visionary), J.P. Morgan (Titan), Ray Dalio (Strategist). Some archetypes run in multiple modes, resulting in 14 advisors total.
Gemini
Claude
ChatGPTFull published thesis
Executive Summary
If you invested $10,000 in BigBear.ai at the forecast anchor (2026-09-18): $6,977 in five years versus $13,892 for S&P 500 benchmark.
20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each stepView tableClose table
Frozen forecast from 18 Sept 2026. Prices in USD; returns exclude dividends. Each quarter is compounded from the previous quarter.
Swipe the table horizontally to read every column.
| Quarter | Target (USD) | Quarter return | Total return | Forecast rationale |
|---|---|---|---|---|
| Q4 2026 | 2.62 | -6.26% | -6.26% | Monetary tightening and discount rate scrutiny deflate speculative multiples. Investors digest persistent cash burn and the 100-million-share shelf overhang, discounting headline contract announcements despite baseline defense procurement stability. |
| Q1 2027 | 2.49 | -4.97% | -10.92% | Full-year 2026 reporting confirms top-line stabilization driven by Ask Sage consolidation, but operating losses remain near $90 million. Substantial share dilution tempers enthusiasm, triggering multiple contraction toward defense contractor peers. |
| Q2 2027 | 2.50 | +0.38% | -10.58% | Incremental airport biometric deployments and task-order wins under federal vehicles provide modest commercial validation. A localized relief rally lifts sentiment, though gains are capped by high overhead and ongoing share issuance. |
| Q3 2027 | 2.40 | -3.96% | -14.12% | Federal fiscal year-end budget debates cause contract authorization slippage. Heavy engineering overhead and selling expenses absorb gross margin gains, prompting fundamental institutional investors to de-risk holdings across unprofitable small-cap defense technology. |
| Q4 2027 | 2.31 | -3.92% | -17.49% | Management taps the active at-the-market equity shelf to finance working capital needs. Year-end tax-loss harvesting and expanding share float overwhelm retail buying interest, driving quoted equity prices lower. |
| Q1 2028 | 2.26 | -2.15% | -19.26% | Audited 2027 results reveal sluggish organic software growth beneath acquired lines, while free cash flow remains negative. Valuation multiples contract as analysts reject pure SaaS multiples in favor of services-heavy benchmarks. |
| Q2 2028 | 2.21 | -2.26% | -21.09% | Classified software installations expand across joint commands, lifting high-margin licensing. Modest sequential gross profit expansion establishes a transient valuation floor, temporarily halting downward momentum across public trading venues. |
| Q3 2028 | 2.18 | -1.25% | -22.07% | Election-cycle budgetary gridlock delays defense appropriations, slowing backlog conversion across national security accounts. Competitive pressure from defense primes squeezes subcontractor margins, reigniting downward drift across the equity base. |
| Q4 2028 | 2.08 | -4.47% | -25.56% | Post-election appropriations unlock delayed task orders, generating a seasonal sentiment lift. However, cumulative share count expansion continues to dilute per-share asset backing, muting overall price recovery into year-end. |
| Q1 2029 | 2.09 | +0.08% | -25.50% | Full-year 2028 disclosures demonstrate top-line growth toward $180 million, but persistent SG&A bloat prevents GAAP operating profitability. Market participants systematically align valuation multiples with low-margin government IT consulting peers. |
| Q2 2029 | 2.11 | +0.94% | -24.80% | Commercial vision deployments across international transport gateways demonstrate cross-selling execution outside federal agencies. Incremental software licensing revenue supports a brief valuation rebound, encouraging specialized technology value allocators. |
| Q3 2029 | 2.08 | -1.15% | -25.66% | Defense budget reprioritization slows non-priority software allocations. Revenue lumpiness resurfaces as contract renewals face extended administrative scrutiny, triggering algorithmic selling as forward growth assumptions are trimmed. |
| Q4 2029 | 2.02 | -2.92% | -27.83% | Restructuring initiatives modestly contain administrative overhead, but ongoing stock-based compensation expands the share float. The market prices the firm strictly as a specialized hybrid defense integrator, capping upside momentum. |
| Q1 2030 | 2.02 | -0.01% | -27.84% | Fiscal 2029 reporting indicates operating cash flow approaching neutral thresholds as Ask Sage reaches critical deployment scale. Relieved solvency fears provide fundamental price support near tangible asset value. |
| Q2 2030 | 2.01 | -0.34% | -28.08% | Remaining ATM shelf capacity is exercised to fund autonomous edge intelligence upgrades. The influx of newly registered common shares dilutes per-share economics, offsetting positive operational news releases. |
| Q3 2030 | 2.00 | -0.71% | -28.60% | Sustained biometric border maintenance billings deliver predictable baseline cash generation. Stable federal procurement cushions operations, establishing an orderly trading range supported by remaining balance sheet cash reserves. |
| Q4 2030 | 1.96 | -1.84% | -29.91% | Macroeconomic stabilization and steady defense IT spending cap downside volatility, though lack of proprietary foundational model scale prevents multiple expansion. Trading volume subsides into seasonal portfolio rebalancing. |
| Q1 2031 | 1.96 | -0.16% | -30.02% | Full-year 2030 statements confirm revenue crossing $220 million with slender operating margins. Growth funds exit toward higher-margin enterprise software platforms, leaving the equity anchored to low single-digit multiples. |
| Q2 2031 | 1.96 | +0.26% | -29.84% | Predictable software maintenance renewals and cost-containment measures support modest operational stability. The enterprise generates sufficient cash to self-fund maintenance, removing distressed discounts while per-share progress remains subdued. |
| Q3 2031 | 1.95 | -0.56% | -30.23% | The five-year forecast horizon concludes with equity valuation fully synchronized to normalized defense contractor economics. Top-line expansion is counterbalanced by historical dilution, leaving shares grounded at intrinsic replacement value. |
The fundamental tension centers on a decoupling between enterprise progress and per-share equity value. Management successfully mitigated insolvency risks by converting $124.6 million of convertible debt and accumulating $409.8 million in cash. However, this balance-sheet fortress was funded by expanding the share count to 479.5 million, with an open 100-million-share shelf creating persistent supply overhang. Operationally, Q2 2026 revenue rebound to $36.7 million and gross margin expansion to 32.8% reflect acquired Ask Sage software, while organic revenue fell 6%. With trailing free cash flow at negative $73.8 million, the company operates as a human-capital-intensive defense integrator rather than a scalable platform. Valuation at over 10x trailing sales must contract toward defense-IT norms of 2.5x to 3.5x.
Key insights
- Dilution decouples growth: enterprise revenue can compound at mid-teens rates while per-share revenue stagnates under ongoing secondary issuance and incentive compensation.
- Gross margin expansion from acquired software wrappers is systematically absorbed by elevated engineering overhead, integration costs, and compliance expenses, postponing GAAP profitability.
- Classified facility accreditations and homeland security incumbency establish a resilient revenue floor, but defense prime gatekeepers capture lead contractor rents.
The company appears to be turning around because it has over $400 million in cash and no immediate bankruptcy risk. However, it achieved this safety by creating hundreds of millions of new shares, which permanently reduces each share's slice of future profits. While sales grew recently due to an acquired software business, the core company still loses money and burns cash delivering customized government IT projects. As investors demand real profits, the stock's expensive artificial-intelligence valuation will likely shrink toward normal defense contractor levels.
Key insights
- Creating massive amounts of new stock means overall sales growth fails to boost individual share value.
- High costs for cleared engineers and administrative overhead consume almost all profits generated from contract wins.
- Steady government defense work prevents business failure but cannot justify an expensive software-like stock price.
Deep Dive
The retail market and speculative momentum traders view the company as an undervalued pure-play defense artificial intelligence disruptor positioned to emulate Palantir. This public narrative anchors heavily on headline sovereign defense spending, recent airport biometric wins, and the optical elimination of convertible debt. The crowd mistakenly treats acquired consulting billings as scalable software subscriptions, while overlooking chronic negative free cash flow and severe per-share share count expansion.